These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25899171)

  • 1. Incident hepatitis among repeat blood donors: A sentinel event signaling possible health care-associated infection and need for reporting to public health authorities.
    Moorman AC; Stramer SL; Schaefer MK; Collier MG; Suryaprasad A; Kuehnert MJ; Moore Z; Rowan E; Habicht K; Bradley K; Fucci MC; Hopkins C; Xu F
    Transfusion; 2015 Oct; 55(10):2531-3. PubMed ID: 25899171
    [No Abstract]   [Full Text] [Related]  

  • 2. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response rate of Malaysian blood donors with reactive screening test to transfusion medicine unit calls.
    Roshan TM; Rosline H; Ahmed SA; Rapiaah M; Khattak MN
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1315-21. PubMed ID: 20578467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological monitoring of natural focal infections in blood donors].
    Nafeev AA; Khapman ME; Avdeeva GA
    Klin Lab Diagn; 2006 Dec; (12):34-5. PubMed ID: 17315675
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15 years screened in the blood bank of a university hospital.
    Dilsiz G; Yenicesu I; Belen FB; Celik B; Ozturk G
    Transfus Apher Sci; 2012 Aug; 47(1):95-100. PubMed ID: 22595695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of donor selection in avoiding hepatitis virus transmission.
    Warson SI
    Scand J Haematol Suppl; 1984; 40():313-5. PubMed ID: 6433458
    [No Abstract]   [Full Text] [Related]  

  • 9. U.S. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.
    Can Dis Wkly Rep; 1991 Nov; 17(46):251-7; discussion 257-8. PubMed ID: 1843654
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.
    Huang Y; Guo N; Yu Q; Lv Y; Ma H; Yun Z; Yao F; Dong X; Zhu X; Wen X; Cao R; Huang M; Bi X; Zhao M; Tiemuer MH; Li J; Zhou Z; He W; Liu J; Wright DJ; Wang J; Ness P; Shan H;
    Transfusion; 2015 Feb; 55(2):388-94. PubMed ID: 25382751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures.
    Preboth M
    Am Fam Physician; 2001 Dec; 64(12):2012-4. PubMed ID: 11775767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk of hepatitis virus B and C transmission during medically assisted reproduction].
    Botta-Fridlund D
    Contracept Fertil Sex; 1994 May; 22(5):298-301. PubMed ID: 8032382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of blood donors questionnaire in a developing country: The case of Gabon.
    Kouegnigan Rerambiah L; Biyoghe AS; Bengone C; Djoba Siawaya JF
    Transfus Clin Biol; 2014 Jun; 21(3):116-9. PubMed ID: 24811564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and incidence of infections among blood donors in Astana].
    Skorikova SV; Burkitbaev ZhK; Savchuk TN; Zhiburt EB
    Vopr Virusol; 2015; 60(1):34-6. PubMed ID: 26021072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual blood donation is safer at small blood collection stations in China.
    Chen SL; Zhang X; Chen ZZ; Wang WJ; Li YL; Li CY; Chen ZL
    Transfus Apher Sci; 2015 Dec; 53(3):315-9. PubMed ID: 26141516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful exclusion of blood-borne viral disease in blood donors.
    Ramezani H; Bozorgi SH; Nooranipour M; Sadri M; Molaverdikhani S; Alavian SM
    Eur J Intern Med; 2011 Dec; 22(6):e71-4. PubMed ID: 22075316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
    Roth WK; Weber M; Seifried E
    Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.